Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy

BACKGROUND: Results from phase III clinical trial CheckMate 025 have established nivolumab as the standard of care for treatment of metastatic renal-cell carcinoma (mRCC) after VEGF inhibitor failure; however, elderly patients are under-represented in the registration trial and little is known about...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitale, Maria Giuseppa, Scagliarini, Sarah, Galli, Luca, Pignata, Sandro, Lo Re, Giovanni, Berruti, Alfredo, Defferrari, Carlotta, Spada, Massimiliano, Masini, Cristina, Santini, Daniele, Ciuffreda, Libero, Ruggeri, Enzo Maria, Bengala, Carmelo, Livi, Lorenzo, Fagnani, Daniele, Bonetti, Andrea, Giustini, Lucio, Hamzaj, Alketa, Procopio, Giuseppe, Caserta, Claudia, Sabbatini, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034807/
https://www.ncbi.nlm.nih.gov/pubmed/29979712
http://dx.doi.org/10.1371/journal.pone.0199642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034807/
https://www.ncbi.nlm.nih.gov/pubmed/29979712
http://dx.doi.org/10.1371/journal.pone.0199642

Ejemplares similares